Cambridge Investment Research Advisors’s Caribou Biosciences CRBU Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$673K	Sell	382,410 -164,604	-30%	-$325K	﹤0.01%	2477
2026 Q1	$1.04M	Sell	547,014 -34,779	-6%	-$59.7K	﹤0.01%	2141
2025 Q4	$925K	Sell	581,793 -594	-0.1%	-$1.25K	﹤0.01%	2158
2025 Q3	$1.36M	Sell	582,387 -2,059	-0.4%	-$3.89K	﹤0.01%	1810
2025 Q2	$736K	Sell	584,446 -27,966	-5%	-$27.5K	﹤0.01%	2197
2025 Q1	$559K	Buy	+612,412	New	+$796K	﹤0.01%	2323

Other funds holding CRBU

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return

NCM

Nelson Capital Management Menlo Park, California $912M AUM 24.01% 1-Year Est. Return

TWM

Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

HHCP

Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM

NWS

Nvest Wealth Strategies Powell, Ohio $160M AUM

Cambridge Investment Research Advisors's CRBU Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Caribou Biosciences (CRBU) stake by 30% in Q2 2026, selling an estimated $325K and leaving 382,410 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.

Cambridge Investment Research Advisors first reported a position in CRBU in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.36M in Q3 2025. 16 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Cambridge Investment Research Advisors held 382,410 shares of Caribou Biosciences worth $673K as of Q2 2026.
Cambridge Investment Research Advisors sold 164,604 Caribou Biosciences shares in Q2 2026, an estimated $325K.
Caribou Biosciences made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2477 holding.
Cambridge Investment Research Advisors first reported a position in Caribou Biosciences in Q1 2025 and has held it in 6 quarters since.
Cambridge Investment Research Advisors's Caribou Biosciences position peaked at $1.36M in Q3 2025.
16 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.